We found 203 records for "Preclinical research"

Articles

Antibiotic resistance: alarm bells ring louder than ever

30th March 2015

 Antibiotic resistance: alarm bells ring louder than everArticles

Though international focus is turning to antimicrobial resistance and incentives are being provided for research into new drugs, there are many hurdles to be jumped before a blockbuster can be...

Read more

Supercomputing is the future of pharmacology

25th March 2015

 Supercomputing is the future of pharmacologyArticles

According to the US FDA, it currently takes about 12 years and £1.1 billion to get a drug from initial idea to market. Supercomputing technology is reducing this time and...

Read more

Protecting the future: the regenerative medicine evolution

10th March 2015

 Protecting the future: the regenerative medicine evolutionArticles

Regenerative medicine has left the realms of sci-fi to become a practical, new form of technology, which can give patients amazing results with serious, previously untreatable injuries. However, the legalities...

Read more

Can the rise in drug-drug interactions be halted, or is it an inevitable side effect?

5th March 2015

 Can the rise in drug-drug interactions be halted, or is it an inevitable side effect?Articles

The trend towards patients taking several medications at the same time is increasing, especially with the ageing population, giving rise to a corresponding rise in the possibility of adverse reactions....

Read more

News

Advanced manufacturing could ‘transform’ biologics development

27th March 2015

 Advanced manufacturing could ‘transform’ biologics developmentNews

Pharma company UCB is part of a consortium which has won UK government funding to help develop next-generation approaches to manufacturing biologics.The UK government has awarded a £6.2 million grant...

Read more

Pharma supports UK genomics effort

26th March 2015

 Pharma supports UK genomics effortNews

Several pharmaceutical companies have formed a coalition to help the UK government bring its 100,000 Genomes Project to fruition.Ten companies – including UK-based pharma majors AstraZeneca (AZ) and GlaxoSmithKline –...

Read more

Roche to use ‘open innovation’ to develop nanotechnology diagnostics

25th February 2015

 Roche to use ‘open innovation’ to develop nanotechnology diagnosticsNews

Roche has announced a new 'open innovation' research alliance in nanotechnology to develop new diagnostic tools.The Swiss company is to work with BioMed X, a new open innovation lab in...

Read more

AZ taps Orca for oral T cell inhibitors

25th February 2015

 AZ taps Orca for oral T cell inhibitorsNews

AstraZeneca (AZ) has forged an R&D alliance with Orca Pharmaceuticals focusing on the development of a new class of compound with potential in autoimmune disease therapy.UK-based Orca was formed in...

Read more

White Papers

Connected data and the use of smartphone enabled apps in market research

11th July 2014

 Connected data and the use of smartphone enabled apps in market researchWhite Papers

Rapid growth in smartphone usage offers healthcare researchers a useful tool to gain better understanding of how patients and healthcare professionals actually behave on a daily basis. Inaccuracies can arise...

Read more

Personalised Medicine – the Future of Blockbuster Pharma?

29th October 2013

 Personalised Medicine – the Future of Blockbuster Pharma?White Papers

The personalised medicine approach is rapidly becoming the new norm for pharmaceutical industry drug development and commercialisation, but it demands much more forward-thinking decision-making, as Phenestra outlines in its latest...

Read more

Round table transcript: Oncology shaping the future of personalised healthcare

2nd October 2013

 Round table transcript: Oncology shaping the future of personalised healthcareWhite Papers

Earlier this year pharmaphorum filmed a round table debate exploring how developments in personalised healthcare cancer treatments are defining the future for this area beyond oncology. In this white paper,...

Read more

Audio & Video

Part three: Oncology shaping the future of personalised healthcare

  In the third part of our video round table debate on how oncology is shaping the future of personalised healthcare, the expert panel focusses on the critical role that pharmaceutical...

Read more

Part two: Oncology shaping the future of personalised healthcare

  Continuing our round table debate on how oncology is shaping the future of personalised healthcare, the participants discuss how healthcare systems need to adapt to support delivery of targeted medicines...

Read more

Events

15th Annual World Vaccine Congress 2015

7th April 2015 - 9th April 2015

15th Annual World Vaccine Congress 2015

Is where the global vaccines industry meets to discuss the commercial and scientific issues around regulation, strategy, manufacturing, trials, partnering, influenza, cancer, emerging disease and veterinary vaccines. Back for its...

Read more

The 2015 Obesity Summit

14th April 2015 - 16th April 2015

The 2015 Obesity Summit

Obesity, is widely recognized as the largest and fastest growing public health problem in the developed and developing world. This three day event will discuss aspects of obesity development...

Read more

PHARMAEXPO International Pharmaceutical Exhibition

15th April 2015 - 17th April 2015

PHARMAEXPO International Pharmaceutical Exhibition

As a part of the VI International Medical Forum “Medicine innovations – the Nation’s health” will be held International Pharmaceutical Exhibition. PHARMAEXPO International Pharmaceutical Exhibition Structure of the exhibition: 1. Medical remedies:...

Read more

Manufacturing of Biologics and Biosimilars

16th April 2015 - 17th April 2015

Manufacturing of Biologics and Biosimilars

Manufacturing of Biologics and Biosimilars offers CMC Introduction Materials-Manufacturing-Control, Regulatory Requirements, Overview Drug Substance-Manufacture, Critical Process Parameters and much more... Key Topics -CMC Introduction Materials-Manufacturing-Control -Regulatory Requirements -Overview Drug Substance-Manufacture -Critical Process...

Read more

Press Releases

Zephyr Health Joins Veeva OpenKey Partner Program

25th March 2015

Zephyr Health Joins Veeva OpenKey Partner Program

Zephyr Health aligns with Veeva on new approach to customer data that’s open and easy San Francisco — March 24, 2015 – Zephyr Health, the only Data Intelligence solution built specifically for health science...

Read more

Digital Health Analytics Goes Mobile With Zephyr Health

24th March 2015

Digital Health Analytics Goes Mobile With Zephyr Health

Zephyr Health launches the first mobile analytics solution for health science companies, designed to bring field representatives and headquarters closer together SAN FRANCISCO -- March 19, 2015 -- Zephyr Health, the...

Read more

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

5th February 2014

Ashfield Commercial & Medical Services redefines healthcare outsourcing to meet pharma's challenges

  Ashfield Commercial & Medical Services   redefines healthcare outsourcing to meet pharma’s challenges   03 February 2014: UDG Healthcare plc (formerly United Drug plc), a leading international provider of services to healthcare manufacturers...

Read more

Unique round table debate brings together key personalised healthcare stakeholders

1st October 2013

Unique round table debate brings together key personalised healthcare stakeholders

AstraZeneca and pharmaphorum media today announced the publication of a unique piece of thought leadership research, via a video round table debate entitled ‘Oncology shaping the future of personalised healthcare’,...

Read more